Tag: ADAPT
COMPASS study finds ADAPT non-inferior to stent retriever for first-line mechanical...
The COMPASS study has found that the use of ADAPT as first-line mechanical thrombectomy therapy for acute ischaemic stroke results in non-inferior functional outcomes...
“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...
Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...
ASTER final data confirm no difference between ADAPT and stent retriever...
The final results of the ASTER randomised controlled trial have confirmed that there was no statistically significant difference between ADAPT (a direct aspiration first...
ASTER RCT finds no significant difference between ADAPT and stent retriever...
The primary results of the ASTER randomised controlled trial (RCT) have shown no statistically significant difference between ADAPT (a direct aspiration first pass technique)...
“Further improvement” in aspiration technology with ACE68
In 2016, Penumbra announced the launch of the ACE68 reperfusion catheter, part of the Penumbra System at the Society of NeuroInterventional Surgery 13th Annual...
Randomised trial of Penumbra 3D revascularisation device meets primary endpoints
The Penumbra 3D trial of the company’s 3D revascularisation device has successfully met the primary trial endpoints, demonstrating non-inferiority in both safety and efficacy...
Penumbra launches ACE 68 reperfusion catheter in USA
Penumbra has launched its new ACE 68 reperfusion catheter in the USA. The catheter is part of the Penumbra System, and was launched at...
Long-term experience confirms ADAPT as effective treatment for stroke
A study of the long-term use of the ADAPT technique for the treatment of acute ischaemic stroke has confirmed that it is an efficient...
Why I use aspiration as my first line treatment for acute...
By Aquilla Turk
In the last year, five prospective randomised clinical trials have demonstrated the superiority of endovascular thrombectomy over medical management for the treatment...
ACE64 study demonstrates high revascularisation rates, quick procedure times
Penumbra has announced that the results of the European multicentre study of the company’s ACE64 thrombectomy system were presented in the Abstract Presentations Session at...
